Catalog No.: PC-62747Not For Human Use, Lab Use Only.
RTC-5 is a dual pathway inhibitor of PI3K-AKT and RAS-ERK signaling via putative activation of the tumor suppressor PP2A, exhibits GI50 of 12.6 uM against H1650 lung adenocarcinoma cells.
RTC-5 (PP2A activator RTC-5, TRC-382) is a dual pathway inhibitor of PI3K-AKT and RAS-ERK signaling via putative activation of the tumor suppressor PP2A, exhibits GI50 of 12.6 uM against H1650 lung adenocarcinoma cells.
RTC-5 (PP2A activator RTC-5, TRC-382) significantly decreases tumor growth in H1650 xenograft in mice.
